What We're Reading: Page 82
Industry reads hand-picked by our editors
Aug 28, 2023
-
CNBC
ADHD drug market faces back-to-school supply strain
-
The New York Times
New RSV Vaccines Aren’t Covered by Some Health Insurance Plans
-
The Wall Street Journal
Cancer Runs in Families. Too Few Are Getting Tested.
-
Politico
The Real Reason Drugs Cost So Much — and Do Too Little
Aug 25, 2023
Aug 24, 2023
-
The Wall Street Journal
Mallinckrodt Lenders to Take Control in Bankruptcy That Cuts $1 Billion in Opioid Payments
-
Fierce Biotech
J&J ends R&D at Janssen’s infectious disease and vaccine unit
-
Bloomberg
Dogs Have a Lyme Disease Vaccine. Now Pfizer Is Making One for People
-
Stat
Vivek Ramaswamy made waves in the debate, much as in biotech
Aug 23, 2023
Aug 22, 2023
Aug 21, 2023
-
C&EN
The challenge of treating childhood brain cancers
-
MIT Technology Review
A chemo drug shortage shows the vulnerability of the healthcare supply chains
-
BioSpace
Roche, Exelixis’ Drug Combo Bounces Back with Late-Stage Prostate Cancer Win
-
The Wall Street Journal
The Booming Business of American Anxiety
Aug 18, 2023
-
The Washington Post
U.S eyes battle with drug giants over 10 costly medications for seniors
-
The Wall Street Journal
America’s Obsession With Weight-Loss Drugs Is Affecting the Economy of Denmark
-
Bloomberg
Pentagon Forms Council to Assess Biothreats, Coordinate Response
Previous
